E-LIB Suche - Ergebnisse für: Lupinacci, Robert

1

Effects of PDE10A inhibitor MK-8189 in people with an acute..:

Mukai, Yuki ; Lupinacci, Robert ; Marder, Stephen...
Schizophrenia Research. 270 (2024) - p. 37-43 , 2024

Link: https://doi.org/10.1016/..

2

A phase 3, single-arm, open-label study to evaluate the saf..:

Maestri, Alvino ; Park, Su Eun ; Fernandes, Fiona...
Human Vaccines & Immunotherapeutics. 20 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Safety and immunogenicity of V114, a 15-valent pneumococcal..:

Quinn, Charles T. ; Wiedmann, Richard T. ; Jarovsky, Daniel...
Blood Advances. 7 (2023) 3 - p. 414-421 , 2023

Link: https://doi.org/10.1182/..

4

A phase 3 study of safety and immunogenicity of V114, a 15-..:

Wilck, Marissa ; Barnabas, Shaun ; Chokephaibulkit, Kulkanya...
AIDS. 37 (2023) 8 - p. 1227-1237 , 2023

Link: https://doi.org/10.1097/..

5

Safety and Immunogenicity of V114 in Preterm Infants: A Poo..:

Chapman, Timothy J. ; Patel, Shrita M. ; Flores, Sheryl A....
Pediatric Infectious Disease Journal. 42 (2023) 11 - p. 1021-1028 , 2023

Link: https://doi.org/10.1097/..

6

P05 Safety, tolerability, and immunogenicity of V114 compar..:

Banniettis, Natalie ; Chapman, Timothy J ; Xu, Shengjie...
JAC-Antimicrobial Resistance. 5 (2023) Supplement_1 - p. , 2023

Link: https://doi.org/10.1093/..

7

Safety, tolerability, and immunogenicity of V114 pneumococc..:

Benfield, Thomas ; Rämet, Mika ; Valentini, Piero...
Vaccine. 41 (2023) 15 - p. 2456-2465 , 2023

Link: https://doi.org/10.1016/..

8

A phase 3, multicenter, randomized, double-blind study to e..:

Bili, Androniki ; Dobson, Scott ; Quinones, Jeffrey...
Vaccine. 41 (2023) 3 - p. 657-665 , 2023

Link: https://doi.org/10.1016/..

9

PCV15, a pneumococcal conjugate vaccine, for the prevention..:

Chapman, Timothy J ; Olarte, Liset ; Dbaibo, Ghassan...
Expert Review of Vaccines. 23 (2023) 1 - p. 137-147 , 2023

Link: https://doi.org/10.1080/..

10

A Phase III, multicenter, randomized, double-blind, active ..:

Martinon-Torres, Federico ; Wysocki, Jacek ; Szenborn, Leszek...
Vaccine. 41 (2023) 21 - p. 3387-3398 , 2023

Link: https://doi.org/10.1016/..

11

A phase 3, multicenter, randomized, double-blind, active-co..:

Lupinacci, Robert ; Rupp, Richard ; Wittawatmongkol, Orasri...
Vaccine. 41 (2023) 5 - p. 1142-1152 , 2023

Link: https://doi.org/10.1016/..

12

P534. Initial Assessment of the Clinical Profile of the PDE..:

Mukai, Yuki ; Lupinacci, Robert ; Marder, Stephen...
Biological Psychiatry. 91 (2022) 9 - p. S305 , 2022

Link: https://doi.org/10.1016/..

13

A phase III, multicenter, randomized, double-blind, active ..:

Banniettis, Natalie ; Wysocki, Jacek ; Szenborn, Leszek...
Vaccine. 40 (2022) 44 - p. 6315-6325 , 2022

Link: https://doi.org/10.1016/..

14

1174. Phase 3 Study to Evaluate the Safety, Tolerability, a..:

Banniettis, Natalie ; Wysocki, Jacek ; Szenborn, Leszek...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S678-S678 , 2021

Link: https://doi.org/10.1093/..

15

1184. A Phase 3, Multicenter, Randomized, Double-blind Stud..:

Bili, Adroniki ; Dobson, Scott ; Quinones, Jeffrey...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S684-S684 , 2021

Link: https://doi.org/10.1093/..